|
1
|
Vazquez ZGS and Klinger JR: Guidelines for
the treatment of pulmonary arterial hypertension. Lung.
198:581–596. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Christou H and Khalil RA: Mechanisms of
pulmonary vascular dysfunction in pulmonary hypertension and
implications for novel therapies. Am J Physiol Heart Circ Physiol.
322:H702–H704. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue
H, Yuan T, Yang P, Xiong F, Zhang S, et al: Blockade of JAK2
protects mice against hypoxia-induced pulmonary arterial
hypertension by repressing pulmonary arterial smooth muscle cell
proliferation. Cell Prolif. 53:e127422020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng YG, Ma H, Chen L, Jiang XM, Zhou L,
Lin S and Chen SL: Efficacy and safety of oral targeted therapies
in pulmonary arterial hypertension: A meta-analysis of randomized
clinical trials. Pulm Circ. 8:20458940187981832018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou J, Kang X, An H, Lv Y and Liu X: The
function and pathogenic mechanism of filamin A. Gene.
784:1455752021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bandaru S, Ala C, Zhou AX and Akyürek LM:
Filamin A regulates cardiovascular remodeling. Int J Mol Sci.
22:65552021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eltahir S, Ahmad KS, Al-Balawi MM,
Bukhamsien H, Al-Mobaireek K, Alotaibi W and Al-Shamrani A: Lung
disease associated with filamin A gene mutation: A case report. J
Med Case Rep. 10:972016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burrage LC, Guillerman RP, Das S, Singh S,
Schady DA, Morris SA, Walkiewicz M, Schecter MG, Heinle JS, Lotze
TE, et al: Lung transplantation for FLNA-associated progressive
lung disease. J Pediatr. 186:118–123.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirashiki A, Adachi S, Nakano Y, Kamimura
Y, Ogo T, Nakanishi N, Morisaki T, Morisaki H, Shimizu A, Toba K,
et al: Left main coronary artery compression by a dilated main
pulmonary artery and left coronary sinus of Valsalva aneurysm in a
patient with heritable pulmonary arterial hypertension and FLNA
mutation. Pulm Circ. 7:734–740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stossel TP, Condeelis J, Cooley L, Hartwig
JH, Noegel A, Schleicher M and Shapiro SS: Filamins as integrators
of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2:138–145.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Retailleau K, Arhatte M, Demolombe S,
Peyronnet R, Baudrie V, Jodar M, Bourreau J, Henrion D, Offermanns
S, Nakamura F, et al: Arterial myogenic activation through smooth
muscle filamin A. Cell Rep. 14:2050–2058. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang L, Li L, Hu E, Chen G, Meng X, Xiong
C and He J: Potential biomarkers and targets in reversibility of
pulmonary arterial hypertension secondary to congenital heart
disease: An explorative study. Pulm Circ. 8:20458932187559872018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
National Research Council (NRC): Institute
for Laboratory Animal Research: Guide for the care and use of
laboratory animals. 8th edition. National Academies Press;
Washington, DC: 2011
|
|
14
|
Gomez-Arroyo J, Saleem SJ, Mizuno S, Syed
AA, Bogaard HJ, Abbate A, Taraseviciene-Stewart L, Sung Y,
Kraskauskas D, Farkas D, et al: A brief overview of mouse models of
pulmonary arterial hypertension: problems and prospects. Am J
Physiol Lung Cell Mol Physiol. 302:L977–L991. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ciuclan L, Bonneau O, Hussey M, Duggan N,
Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, et al:
A novel murine model of severe pulmonary arterial hypertension. Am
J Respir Crit Care Med. 184:1171–1182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vitali SH, Hansmann G, Rose C,
Fernandez-Gonzalez A, Scheid A, Mitsialis SA and Kourembanas S: The
Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited:
Long-term follow-up. Pulm Circ. 4:619–629. 2014. View Article : Google Scholar
|
|
17
|
Liu PF, Zhang AK, Ding Z, Dai D, Li B, Liu
SF, Xu J, Cheng Z, Zhao S, Zhao X and Dong J: m6A
modification-mediated GRAP regulates vascular remodeling in hypoxic
pulmonary hypertension. Am J Respir Cell Mol Biol. 67:574–588.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Woo MS, Ohta Y, Rabinovitz I, Stossel TP
and Blenis J: Ribosomal S6 kinase (RSK) regulates phosphorylation
of filamin A on an important regulatory site. Mol Cell Biol.
24:3025–3035. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang L, Li L, Yang T, Li W, Song L, Meng
X, Gu Q, Xiong C and He J: Transgelin as a potential target in the
reversibility of pulmonary arterial hypertension secondary to
congenital heart disease. J Cell Mol Med. 22:6249–6261. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Casique-Aguirre D, Briseño-Díaz P,
García-Gutiérrez P, la Rosa CHG, Quintero-Barceinas RS,
Rojo-Domínguez A, Vergara I, Medina LA, Correa-Basurto J, Bello M,
et al: KRas4B-PDE6δ complex stabilization by small molecules
obtained by virtual screening affects Ras signaling in pancreatic
cancer. BMC Cancer. 18:12992018. View Article : Google Scholar
|
|
22
|
Feng Y, Chen MH, Moskowitz IP, Mendonza
AM, Vidali L, Nakamura F, Kwiatkowski DJ and Walsh CA: Filamin A
(FLNA) is required for cell-cell contact in vascular development
and cardiac morphogenesis. Proc Natl Acad Sci USA. 103:19836–19841.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng X, Li S, Qiu Q, Jin B, Yan M, Hu Y,
Wu Y, Zhou H, Zhang G and Zheng X: Where the congenital heart
disease meets the pulmonary arterial hypertension, FLNA matters: A
case report and literature review. BMC Pediatr. 20:5042020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Demirel N, Ochoa R, Dishop MK, Holm T,
Gershan W and Brottman G: Respiratory distress in a 2-month-old
infant: Is the primary cause cardiac, pulmonary or both? Respir Med
Case Rep. 25:61–65. 2018.PubMed/NCBI
|
|
25
|
Masurel-Paulet A, Haan E, Thompson EM,
Goizet C, Thauvin-Robinet C, Tai A, Kennedy D, Smith G, Khong TY,
Solé G, et al: Lung disease associated with periventricular nodular
heterotopia and an FLNA mutation. Eur J Med Genet. 54:25–28. 2011.
View Article : Google Scholar
|
|
26
|
Sasaki E, Byrne AT, Phelan E, Cox DW and
Reardon W: A review of filamin A mutations and associated
interstitial lung disease. Eur J Pediatr. 178:121–129. 2019.
View Article : Google Scholar
|
|
27
|
Zheng X, Zhou AX, Rouhi P, Uramoto H,
Borén J, Cao Y, Pereira T, Akyürek LM and Poellinger L:
Hypoxia-induced and calpain-dependent cleavage of filamin A
regulates the hypoxic response. Proc Natl Acad Sci USA.
111:2560–2565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang K, Ash JF and Singer SJ: Filamin, a
new high-molecular-weight protein found in smooth muscle and
non-muscle cells. Proc Natl Acad Sci USA. 72:4483–4486. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jain M, Weber A, Maly K, Manjaly G, Deek
J, Tsvyetkova O, Stulić M, Toca-Herrera JL and Jantsch MF: A-to-I
RNA editing of filamin A regulates cellular adhesion, migration and
mechanical properties. FEBS J. 289:4580–4601. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karimi A and Milewicz DM: Structure of the
elastin-contractile units in the thoracic aorta and how genes that
cause thoracic aortic aneurysms and dissections disrupt this
structure. Can J Cardiol. 32:26–34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu N, Erb L, Shivaji R, Weisman GA and
Seye CI: Binding of the P2Y2 nucleotide receptor to filamin A
regulates migration of vascular smooth muscle cells. Circ Res.
102:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pena E, Arderiu G and Badimon L:
Subcellular localization of tissue factor and human coronary artery
smooth muscle cell migration. J Thromb Haemost. 10:2373–2382. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Retailleau K, Arhatte M, Demolombe S,
Jodar M, Baudrie V, Offermanns S, Feng Y, Patel A, Honoré E and
Duprat F: Smooth muscle filamin A is a major determinant of conduit
artery structure and function at the adult stage. Pflugers Arch.
468:1151–1160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Wei X, Zhang ZH, He Y, Huo B, Guo
X, Feng X, Fang ZM, Jiang DS and Zhu XH: Downregulation of filamin
A expression in the aorta is correlated with aortic dissection.
Front Cardiovasc Med. 8:6908462021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maceyka M, Alvarez SE, Milstien S and
Spiegel S: Filamin A links sphingosine kinase 1 and
sphingosine-1-phosphate receptor 1 at lamellipodia to orchestrate
cell migration. Mol Cell Biol. 28:5687–5697. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta
Y, Stossel TP and Kumar R: Filamin is essential in actin
cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell
Biol. 4:681–690. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shimokawa H, Sunamura S and Satoh K:
RhoA/Rho-kinase in the cardiovascular system. Circ Res.
118:352–366. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dilasser F, Rio M, Rose L, Tesse A,
Guignabert C, Loirand G and Sauzeau V: Smooth muscle Rac1
contributes to pulmonary hypertension. Br J Pharmacol.
179:3418–3429. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Johnson JA, Hemnes AR, Perrien DS,
Schuster M, Robinson LJ, Gladson S, Loibner H, Bai S, Blackwell TR,
Tada Y, et al: Cytoskeletal defects in Bmpr2-associated pulmonary
arterial hypertension. Am J Physiol Lung Cell Mol Physiol.
302:L474–L484. 2012. View Article : Google Scholar :
|
|
40
|
Kim HJ, Ryu KJ, Kim MJ, Kim T, Kim SH, Han
H, Kim H, Hong KS, Song Y, Choi Y, et al: RhoGDI2-mediated rac1
recruitment to filamin A enhances Rac1 activity and promotes
invasive abilities of gastric cancer cells. Cancers (Basel).
14:2552022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hinoki A, Kimura K, Higuchi S, Eguchi K,
Takaguri A, Ishimaru K, Frank GD, Gerthoffer WT, Sommerville LJ,
Autieri MV and Eguchi S: p21-activated kinase 1 participates in
vascular remodeling in vitro and in vivo. Hypertension. 55:161–165.
2010. View Article : Google Scholar
|
|
42
|
Wang D, Paria BC, Zhang Q, Karpurapu M, Li
Q, Gerthoffer WT, Nakaoka Y and Rao GN: A role for Gab1/SHP2 in
thrombin activation of PAK1: Gene transfer of kinase-dead PAK1
inhibits injury-induced restenosis. Circ Res. 104:1066–1075. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fediuk J, Sikarwar AS, Nolette N and
Dakshinamurti S: Thromboxane-induced actin polymerization in
hypoxic neonatal pulmonary arterial myocytes involves Cdc42
signaling. Am J Physiol Lung Cell Mol Physiol. 307:L877–L887. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Diebold I, Petry A, Djordjevic T, Belaiba
RS, Fineman J, Black S, Schreiber C, Fratz S, Hess J, Kietzmann T
and Görlach A: Reciprocal regulation of Rac1 and PAK-1 by
HIF-1alpha: A positive-feedback loop promoting pulmonary vascular
remodeling. Antioxid Redox Signal. 13:399–412. 2010. View Article : Google Scholar
|
